Biocogniv Competitor Insights

Biocogniv is a digital diagnostics company that leverages artificial intelligence and laboratory data to improve patient outcomes in acute care settings. Their flagship product, Sepsis aiMarker™, helps detect sepsis up to 72 hours in advance using routine blood tests. The company has received FDA Breakthrough Designation for this product, demonstrating its potential to transform sepsis diagnosis and management.